Novel compounds

Details for Australian Patent Application No. 2005227365 (hide)

Owner SmithKline Beecham p.l.c. Glaxo House SmithKline Beecham Corporation

Inventors Martensen, Shelby A.; Smith, Randall F.; Xie, Qing; Lai, Ying-Ta; Cogswell, John P.; Agarwal, Pankaj; Strum, Jay C.

Agent Davies Collison Cave

Pub. Number AU-A-2005227365

Parent 2001292619

Filing date 26 October 2005

Wipo publication date 17 November 2005

International Classifications

C12N 015/12 Mutation or genetic engineering - Genes encoding animal proteins

C07K 014/435 Peptides having more than 20 amino acids - from animals

C12N 015/00 Mutation or genetic engineering

Event Publications

10 November 2005 Complete Application Filed

17 November 2005 Application Open to Public Inspection

  Published as AU-A-2005227365

17 November 2005 Corrigenda

  Complete Applications Filed - Name Index Under the names Glaxo House, SmithKline Beecham Corporation and SmithKline Beecham p.l.c., Application No. 2005227365, under INID (71) correct the names to read Glaxo Group Limited, SmithKline Beecham Corporation and SmithKline Beecham p.l.c.

1 May 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005227366-Mobile robot having body sensor

2005227364-Peptide-lipid conjugates, liposomes and liposomal drug delivery